-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cerebral vein thrombosis (CVT) due to vaccine-induced immune thrombocytopenia (VITT) is a serious disease with a high
The researchers used data from an international registry that collected patients who
Results showed that of the 107 CVT-VITT cases, 43 (40%) died
In summary, compared with the high mortality rate of CVT-VITT in the acute phase, the mortality rate of patients who survived the initial hospitalization was very low, no new thrombotic events occurred, and bleeding events were rare
References:
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.